The metabolism of proline as microenvironmental stress substrate

被引:131
作者
Phang, James M. [1 ]
Pandhare, Jui [1 ]
Liu, Yongmin [2 ]
机构
[1] NCI, Comparat Carcinogenesis Lab, Ctr Canc Res, Frederick, MD 21702 USA
[2] NCI, Basic Res Program, Sci Applicat Int Corp, Frederick, MD 21702 USA
关键词
D O I
10.1093/jn/138.10.2008S
中图分类号
R15 [营养卫生、食品卫生]; TS201 [基础科学];
学科分类号
100403 ;
摘要
Proline, a unique proteogenic secondary amino acid, has its own metabolic system with special features. Recent findings defining the regulation of this system led us to propose that proline is a stress substrate in the microenvironment of inflammation and tumorigenesis. The criteria for proline as a stress substrate are: 1) the enzymes utilizing proline respond to stress signaling; 2) there is a large, mobilizable pool of proline, and 3) the metabolism of proline serves special stress functions. Studies show that the proline-utilizing enzyme, proline oxidase (POX)/proline dehydrogenase (PRODH), responds to genotoxic, inflammatory, and nutrient stress. Proline as substrate is stored as collagen in extracellular matrix, connective tissue, and bone and it is rapidly released from this reservoir by the sequential action of matrix metalloproteinases, peptidases, and prolidase. Special functions include the use of proline by POX/PRODH to generate superoxide radicals that initiate apoptosis by intrinsic and extrinsic pathways. Under conditions of nutrient stress, proline is an energy source. It provides carbons for the tricarboxylic acid cycle and also participates in the proline cycle. The latter, catalyzed by mitochondrial POX and cytosolic pyrroline-5-carboxylate reductase, shuttles reducing potential from the pentose phosphate pathway into mitochondria to generate ATP and oxidizing potential to activate the cytosolic pentose phosphate pathway.
引用
收藏
页码:2008S / 2015S
页数:8
相关论文
共 74 条
[21]   TRANSFER OF REDUCING EQUIVALENTS INTO MITOCHONDRIA BY THE INTERCONVERSIONS OF PROLINE AND DELTA-1-PYRROLINE-5-CARBOXYLATE [J].
HAGEDORN, CH ;
PHANG, JM .
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS, 1983, 225 (01) :95-101
[22]   Peroxisome proliferator-activated receptor γ:: a novel target for cancer therapeutics? [J].
Han, ShouWei ;
Roman, Jesse .
ANTI-CANCER DRUGS, 2007, 18 (03) :237-244
[23]   Expanded approach to tolerable upper intake guidelines for nutrients and bioactive substances [J].
Hathcock, John N. ;
Shao, Andrew .
JOURNAL OF NUTRITION, 2008, 138 (10) :1992S-1995S
[24]  
Hu Chien-An A., 2001, Proceedings of the American Association for Cancer Research Annual Meeting, V42, P225
[25]   Metabolic catastrophe as a means to cancer cell death [J].
Jin, Shengkan ;
DiPaola, Robert S. ;
Mathew, Robin ;
White, Eileen .
JOURNAL OF CELL SCIENCE, 2007, 120 (03) :379-383
[26]   ACID-BASE ALTERATIONS AND RENAL GLUCONEOGENESIS - EFFECT OF PH BICARBONATE CONCENTRATION AND PCO2 [J].
KAMM, DE ;
FUISZ, RE ;
GOODMAN, AD ;
CAHILL, GF .
JOURNAL OF CLINICAL INVESTIGATION, 1967, 46 (07) :1172-&
[27]   Apoptotic action of peroxisome proliferator-activated receptor-γ activation in human non-small-cell lung cancer is mediated via proline oxidase-induced reactive oxygen species formation [J].
Kim, Ki Young ;
Ahn, Jin Hee ;
Cheon, Hyae Gyeong .
MOLECULAR PHARMACOLOGY, 2007, 72 (03) :674-685
[28]   The 7th workshop on the assessment of adequate intake of dietary amino acids: Summary of general discussion [J].
Kimura, Takeshi ;
Renwick, Andrew G. ;
Kadowaki, Motoni ;
Cynober, Luc A. .
JOURNAL OF NUTRITION, 2008, 138 (10) :2050S-2052S
[29]   The evolving concept of tumor microenvironments [J].
Laconi, Ezio .
BIOESSAYS, 2007, 29 (08) :738-744
[30]   Function of PPAR-γ and its ligands in lung cancer [J].
Li, MY ;
Lee, TW ;
Yim, APC ;
Chen, GG .
CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2006, 43 (02) :183-202